The combination of tamoxifen and SP600125 significantly diminished tumour weight, tumour cell proliferation and c-Jun phosphorylation (Fig. 6f–h and Supplementary Fig. 6a) without inducing nephrotoxicity or liver toxicity (Supplementary Fig. 6b). The gene discussed is JUN; the disease is neoplasm.